Rasburnat Injection
Marketer
Natco Pharma Ltd
Salt Composition
Rasburicase (1.5mg)
Overview Rasburnat Injection
Chemotherapy-induced hyperuricemia is treated with Rasburnat Injection, a medication that reduces blood uric acid levels, thus mitigating potential kidney damage in oncology patients. Administered intravenously by a healthcare professional at a carefully determined dosage and frequency, the prescribed regimen is tailored to individual needs and may fluctuate. Strict adherence to the physician's instructions is crucial, as incorrect usage or overdosage can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, typically manifesting after several weeks or months, discontinuation should only occur under medical supervision. Commonly reported side effects encompass nausea, headache, vomiting, and rash. However, serious adverse events such as respiratory distress, chest pain, facial or throat swelling, pruritus, or vertigo necessitate immediate medical attention. Regular blood uric acid monitoring is often employed during treatment. Hydration is encouraged to prevent dehydration. Complete disclosure of all current medications and pre-existing health conditions is essential to ensure treatment safety and efficacy due to potential drug interactions.
Uses of Rasburnat Injection
Managing hyperuricemia resulting from cytotoxic therapy
Major Benefits of Rasburnat Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Rasburnat Injection:
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rasburnat Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rasburnat Injection works:
Rasburnat Injection functions by interacting with a specific enzyme, converting uric acid into the inert compound allantoin, thus lowering overall uric acid concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rasburnat Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rasburnat Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Rasburnat Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Rasburnat Injection on driving ability is undetermined. Refrain from driving if you encounter any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rasburnat Injection is likely safe for individuals with impaired kidney function. Available evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Rasburnat Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Rasburnat Injection :
NA
Facts to Know About Rasburnat Injection
| Label | Value |
|---|---|
| Chemical Type | Recombinant Xanthine Oxidoreductase |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Class | Chemotherapy with uricolytic agents |
3,018 People bought this recently